$GEVO

Gendenjamts Davaajargal sold $6K of GEVO

Gendenjamts Davaajargal (VP Acctg and Treasurer) sold 4,293 shares of Gevo, Inc. (GEVO) at $1.43 on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gendenjamts Davaajargal
Published Jun 15, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:15 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
high confidence
Mentioned
$GEVO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The disclosed sale is small in absolute terms ($6,118.38) and explicitly tied to a pre-arranged 10b5-1 plan, reducing interpretive weight.

02

Market read

Traders may note the insider sale for sentiment, but there is no new fundamental information to drive repricing.

03

What to watch

The article provides no follow-on insider buying, no change in guidance, and no linkage to operational or financial catalysts.

Relevance 2/10Novelty 3/10Timing: Filed 2026-06-15, transaction dated 2026-06-12.

Background

The article is a SEC Form 4 insider transaction disclosure for Gevo, Inc.

Company-level read

Ticker impact

$GEVONeutralHigh confidence
Context

Gevo Form 4 shows VP Accounting and Treasurer Gendenjamts Davaajargal sold 4,293 shares at $1.4252 on a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a routine Form 4 transaction with explicit 10b5-1 pre-arrangement, and it does not disclose new company fundamentals.

Market effects

No clear sector read-through from a single routine 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is on a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Gevo, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Gendenjamts Davaajargal

    VP Accounting and Treasurer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.